NASDAQ:DRIO - DarioHealth Stock Price, Price Target & More

Sign in or create an account to add this stock to your watchlist.
$1.59 -0.02 (-1.24 %)
(As of 05/25/2018 04:00 PM ET)
Previous Close$1.61
Today's Range$1.59 - $1.64
52-Week Range$1.32 - $3.64
Volume12,800 shs
Average Volume60,796 shs
Market Capitalization$26.96 million
P/E RatioN/A
Dividend YieldN/A
Beta-1.78

About DarioHealth (NASDAQ:DRIO)

DarioHealth Corp., a digital health company, develops and commercializes patented and proprietary technologies providing consumers with laboratory-testing capabilities using smart phones and other mobile devices in the United States, Europe, Australia, and Canada. The company's flagship product, Dario, also known as Dario Smart Diabetes Management Solution, is a mobile, real-time, cloud-based, diabetes management solution based on a software application combined with Dario Smart Meter, a pocket-sized, blood glucose monitoring device. It offers Dario Engage software platform, where the company digitally engages with Dario users and assists them in monitoring their chronic illnesses, as well as provides them with coaching, support, digital communications, and real time alerts, trends, and pattern analysis. DarioHealth Corp. markets its products directly to consumer cash sales, as well as retail pharmacy and distributors; and through e-stores. The company was formerly known as LabStyle Innovations Corp. and changed its name to DarioHealth Corp. in July 2016. DarioHealth Corp. was founded in 2011 and is headquartered in Caesarea, Israel.

Receive DRIO News and Ratings via Email

Sign-up to receive the latest news and ratings for DRIO and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Surgical & medical instruments
Sub-IndustryN/A
SectorMedical
SymbolNASDAQ:DRIO
CUSIPN/A
Phone972-4770-4055

Debt

Debt-to-Equity RatioN/A
Current Ratio3.71
Quick Ratio3.33

Price-To-Earnings

Trailing P/E RatioN/A
Forward P/E RatioN/A
P/E GrowthN/A

Sales & Book Value

Annual Sales$5.17 million
Price / Sales5.15
Cash FlowN/A
Price / CashN/A
Book Value$0.44 per share
Price / Book3.61

Profitability

EPS (Most Recent Fiscal Year)($1.64)
Net Income$-15,740,000.00
Net Margins-374.45%
Return on Equity-414.86%
Return on Assets-269.39%

Miscellaneous

Employees48
Outstanding Shares16,740,000

DarioHealth (NASDAQ:DRIO) Frequently Asked Questions

What is DarioHealth's stock symbol?

DarioHealth trades on the NASDAQ under the ticker symbol "DRIO."

How were DarioHealth's earnings last quarter?

DarioHealth (NASDAQ:DRIO) released its earnings results on Tuesday, May, 15th. The company reported ($0.20) earnings per share for the quarter, missing analysts' consensus estimates of ($0.19) by $0.01. The company earned $1.76 million during the quarter. DarioHealth had a negative net margin of 374.45% and a negative return on equity of 414.86%. View DarioHealth's Earnings History.

When is DarioHealth's next earnings date?

DarioHealth is scheduled to release their next quarterly earnings announcement on Monday, August, 13th 2018. View Earnings Estimates for DarioHealth.

What price target have analysts set for DRIO?

2 analysts have issued 1-year price objectives for DarioHealth's stock. Their forecasts range from $3.50 to $3.50. On average, they expect DarioHealth's share price to reach $3.50 in the next year. View Analyst Ratings for DarioHealth.

Who are some of DarioHealth's key competitors?

Who are DarioHealth's key executives?

DarioHealth's management team includes the folowing people:
  • Mr. Erez Raphael, CEO, Pres & Chairman (Age 45)
  • Mr. Zvi Ben David CPA, CFO, Treasurer & Sec. (Age 57)
  • Shmuel Herschberg, Marketing Director

Has DarioHealth been receiving favorable news coverage?

Media coverage about DRIO stock has trended somewhat positive on Saturday, according to Accern. Accern identifies negative and positive media coverage by monitoring more than 20 million news and blog sources. Accern ranks coverage of publicly-traded companies on a scale of negative one to positive one, with scores closest to one being the most favorable. DarioHealth earned a media sentiment score of 0.11 on Accern's scale. They also assigned news articles about the company an impact score of 45.04 out of 100, meaning that recent media coverage is somewhat unlikely to have an impact on the stock's share price in the immediate future.

How do I buy shares of DarioHealth?

Shares of DRIO can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is DarioHealth's stock price today?

One share of DRIO stock can currently be purchased for approximately $1.59.

How big of a company is DarioHealth?

DarioHealth has a market capitalization of $26.96 million and generates $5.17 million in revenue each year. The company earns $-15,740,000.00 in net income (profit) each year or ($1.64) on an earnings per share basis. DarioHealth employs 48 workers across the globe.

How can I contact DarioHealth?

DarioHealth's mailing address is 8 HaToKhen Street, Caesarea Industrial Park L3, 3088900. The company can be reached via phone at 972-4770-4055 or via email at [email protected]


MarketBeat Community Rating for DarioHealth (DRIO)

Community Ranking:  2.9 out of 5 (star star)
Outperform Votes:  92 (Vote Outperform)
Underperform Votes:  66 (Vote Underperform)
Total Votes:  158
MarketBeat's community ratings are surveys of what our community members think about DarioHealth and other stocks. Vote "Outperform" if you believe DRIO will outperform the S&P 500 over the long term. Vote "Underperform" if you believe DRIO will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

DarioHealth (NASDAQ:DRIO) Price Target and Consensus Rating

  (How are Consensus Ratings Calculated?)
2 Wall Street analysts have issued ratings and price targets for DarioHealth in the last 12 months. Their average twelve-month price target is $3.50, suggesting that the stock has a possible upside of 120.13%. The high price target for DRIO is $3.50 and the low price target for DRIO is $3.50. There are currently 2 buy ratings for the stock, resulting in a consensus rating of "Buy."
Today30 Days Ago90 Days Ago180 Days Ago
Consensus Rating: BuyBuyBuyBuy
Consensus Rating Score: 3.003.003.003.00
Ratings Breakdown: 0 Sell Rating(s)
0 Hold Rating(s)
2 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
2 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
2 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
2 Buy Rating(s)
0 Strong Buy Rating(s)
Consensus Price Target: $3.50$3.50$5.75$5.75
Price Target Upside: 120.13% upside122.93% upside302.10% upside187.50% upside

DarioHealth (NASDAQ:DRIO) Consensus Price Target History

Price Target History for DarioHealth (NASDAQ:DRIO)

DarioHealth (NASDAQ:DRIO) Analyst Ratings History

Show:
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
4/9/2018Chardan CapitalInitiated CoverageBuyHighView Rating Details
12/8/2017AegisReiterated RatingBuyLowView Rating Details
3/27/2017HC WainwrightSet Price TargetBuy$8.00MediumView Rating Details
8/22/2016Rodman & RenshawReiterated RatingBuy$12.00N/AView Rating Details
(Data available from 5/26/2016 forward)

Earnings

DarioHealth (NASDAQ:DRIO) Earnings History and Estimates Chart

Earnings by Quarter for DarioHealth (NASDAQ:DRIO)

DarioHealth (NASDAQ DRIO) Earnings History by Quarter

DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
8/13/2018($0.20)N/AView Earnings Details
5/15/2018Q1($0.19)($0.20)$1.76 millionViewN/AView Earnings Details
3/19/2018Before Market($0.28)($1.23)$1.58 millionViewListenView Earnings Details
11/14/2017Q3 2017($0.29)($0.30)$1.38 millionViewN/AView Earnings Details
8/14/20176/30/2017($0.30)($0.43)$1.21 millionViewN/AView Earnings Details
5/15/20173/31/2017($0.47)$0.45$1.01 millionViewN/AView Earnings Details
3/22/2017Q4 2016($0.96)$0.84 millionViewN/AView Earnings Details
11/10/2016Q316($0.41)($0.31)$0.77 million$0.73 millionViewN/AView Earnings Details
8/11/2016Q2 2016($0.35)($0.49)$0.83 million$0.67 millionViewN/AView Earnings Details
5/11/2016Q1 2016($0.38)($0.33)$0.56 million$0.57 millionViewN/AView Earnings Details
2/9/2016Q4 2015($0.54)$0.31 millionViewN/AView Earnings Details
11/13/2015Q3 2015($0.90)$0.27 millionViewN/AView Earnings Details
8/13/2015Q2 2015($1.26)$0.18 millionViewN/AView Earnings Details
5/15/2015Q1 2015($1.44)$0.07 millionViewN/AView Earnings Details
11/14/2014Q3 2014($0.70)($0.25)$0.50 millionViewN/AView Earnings Details
8/15/2014Q2 2014($11.69)($14.39)ViewN/AView Earnings Details
5/15/2014Q1 2014($14.39)($12.59)ViewN/AView Earnings Details
11/12/2013Q3 2013($16.19)($15.29)ViewN/AView Earnings Details
8/14/2013Q2 2013($15.29)($14.39)ViewN/AView Earnings Details
5/14/2013Q1 2013($15.29)ViewN/AView Earnings Details
(Earnings results data provided by Zacks Investment Research)

Dividends

DarioHealth (NASDAQ:DRIO) Dividend History by Quarter

AnnouncedPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
(Data available from 1/1/2013 forward)

Insider Trades

DarioHealth (NASDAQ DRIO) Insider Trading and Institutional Ownership History

Insider Ownership Percentage: 27.80%
Institutional Ownership Percentage: 1.18%
Insider Trading History for DarioHealth (NASDAQ:DRIO)

DarioHealth (NASDAQ DRIO) Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
2/28/2018Zvi Ben-DavidCFOBuy9,018$1.40$12,625.20View SEC Filing  
8/19/2016Erez RaphaelCEOBuy500$3.57$1,785.00111,129View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

DarioHealth (NASDAQ DRIO) News Headlines

Source:
DateHeadline
DarioHealth to Present at Chardans Digital Health ConferenceDarioHealth to Present at Chardan's Digital Health Conference
finance.yahoo.com - May 21 at 4:17 PM
DarioHealths (DRIO) CEO Erez Raphael on Q1 2018 Results - Earnings Call TranscriptDarioHealth's (DRIO) CEO Erez Raphael on Q1 2018 Results - Earnings Call Transcript
seekingalpha.com - May 15 at 4:34 PM
DarioHealth (DRIO) Announces  Earnings Results, Misses Expectations By $0.01 EPSDarioHealth (DRIO) Announces Earnings Results, Misses Expectations By $0.01 EPS
www.americanbankingnews.com - May 15 at 11:59 AM
DarioHealth misses by $0.01, beats on revenueDarioHealth misses by $0.01, beats on revenue
seekingalpha.com - May 15 at 10:20 AM
DarioHealth Reports First Quarter 2018 ResultsDarioHealth Reports First Quarter 2018 Results
finance.yahoo.com - May 15 at 10:20 AM
DarioHealth Releases Next Generation Version 4.0 of its Award-Winning AppDarioHealth Releases Next Generation Version 4.0 of its Award-Winning App
finance.yahoo.com - May 8 at 9:36 AM
DarioHealth (DRIO) Set to Announce Earnings on TuesdayDarioHealth (DRIO) Set to Announce Earnings on Tuesday
www.americanbankingnews.com - May 8 at 2:44 AM
DarioHealth (DRIO) Raised to Hold at ValuEngineDarioHealth (DRIO) Raised to Hold at ValuEngine
www.americanbankingnews.com - May 3 at 10:54 PM
DarioHealth to Host First Quarter 2018 Conference Call on May 15, 2018DarioHealth to Host First Quarter 2018 Conference Call on May 15, 2018
finance.yahoo.com - May 2 at 9:36 AM
DarioHealth Ramps up Commercialization CapabilitiesDarioHealth Ramps up Commercialization Capabilities
finance.yahoo.com - April 30 at 9:54 AM
BRIEF-Dariohealth Corp Says Selling Stockholders May Offer From Time To Time Up To 8.5 Mln sharesBRIEF-Dariohealth Corp Says Selling Stockholders May Offer From Time To Time Up To 8.5 Mln shares
www.reuters.com - April 27 at 10:15 AM
Analyst Actions: Chardan Initiates Coverage on DarioHealth With Buy Rating and $4 PTAnalyst Actions: Chardan Initiates Coverage on DarioHealth With Buy Rating and $4 PT
www.nasdaq.com - April 9 at 4:14 PM
Chardan Capital Initiates Coverage on DarioHealth (DRIO)Chardan Capital Initiates Coverage on DarioHealth (DRIO)
www.americanbankingnews.com - April 9 at 8:12 AM
DarioHealth, New Glucose Monitoring System, Climbing Revenue, and Analysts TargetDarioHealth, New Glucose Monitoring System, Climbing Revenue, and Analysts Target
finance.yahoo.com - April 4 at 5:17 PM
DarioHealth Launches Customer Hotline to Pre-Order Its Apple iPhone Lightning-Compatible Glucose Monitor in the U.S.DarioHealth Launches Customer Hotline to Pre-Order Its Apple iPhone Lightning-Compatible Glucose Monitor in the U.S.
finance.yahoo.com - March 29 at 10:08 AM
SHAREHOLDER ALERT: Levi & Korsinsky, LLP Announces an Investigation Concerning Possible Breaches of Fiduciary Duty by Certain Officers and Directors of DarioHealth Corp.SHAREHOLDER ALERT: Levi & Korsinsky, LLP Announces an Investigation Concerning Possible Breaches of Fiduciary Duty by Certain Officers and Directors of DarioHealth Corp.
finance.yahoo.com - March 27 at 10:10 AM
DarioHealth (DRIO) Announces FDA Clearance for iPhone 7, 8 and iPhone X Smart Glucose MeterDarioHealth (DRIO) Announces FDA Clearance for iPhone 7, 8 and iPhone X Smart Glucose Meter
www.streetinsider.com - March 26 at 4:09 PM
DarioHealth receives U.S. FDA clearance for iPhone 7, 8 and Iphone X Smart Glucose Meter; shares ahead 34% premarketDarioHealth receives U.S. FDA clearance for iPhone 7, 8 and Iphone X Smart Glucose Meter; shares ahead 34% premarket
seekingalpha.com - March 26 at 10:11 AM
DarioHealth stock soars after iPhone-compatible glucose monitor receives FDA clearanceDarioHealth stock soars after iPhone-compatible glucose monitor receives FDA clearance
finance.yahoo.com - March 26 at 10:11 AM
DarioHealth Receives U.S. FDA Clearance for iPhone 7, 8 and iPhone X Smart Glucose MeterDarioHealth Receives U.S. FDA Clearance for iPhone 7, 8 and iPhone X Smart Glucose Meter
finance.yahoo.com - March 26 at 10:11 AM
ValuEngine Upgrades DarioHealth (DRIO) to "Sell"ValuEngine Upgrades DarioHealth (DRIO) to "Sell"
www.americanbankingnews.com - March 25 at 6:58 PM
DarioHealth (DRIO) Announces  Earnings Results, Misses Expectations By $0.95 EPSDarioHealth (DRIO) Announces Earnings Results, Misses Expectations By $0.95 EPS
www.americanbankingnews.com - March 19 at 1:49 PM
Are Earnings Prospects Improving For Loss-Making DarioHealth Corp’s (NASDAQ:DRIO)?Are Earnings Prospects Improving For Loss-Making DarioHealth Corp’s (NASDAQ:DRIO)?
finance.yahoo.com - March 19 at 9:53 AM
DarioHealth Reports Fourth Quarter and Year End 2017 ResultsDarioHealth Reports Fourth Quarter and Year End 2017 Results
finance.yahoo.com - March 19 at 9:53 AM
DarioHealth Announces Revised Date for Fourth Quarter and Year End 2017 Conference CallDarioHealth Announces Revised Date for Fourth Quarter and Year End 2017 Conference Call
finance.yahoo.com - March 14 at 10:46 AM
DarioHealth to Host Fourth Quarter and Year End 2017 Conference Call on March 20, 2018DarioHealth to Host Fourth Quarter and Year End 2017 Conference Call on March 20, 2018
finance.yahoo.com - March 8 at 10:07 AM
DarioHealth Presents Dario Engage Vision at the HIMSS Annual Conference & ExhibitionDarioHealth Presents Dario Engage Vision at the HIMSS Annual Conference & Exhibition
finance.yahoo.com - March 5 at 9:59 AM
DarioHealth Corp (DRIO) CFO Zvi Ben-David Acquires 9,018 SharesDarioHealth Corp (DRIO) CFO Zvi Ben-David Acquires 9,018 Shares
www.americanbankingnews.com - March 2 at 7:34 PM
BRIEF-Dariohealth Launches Sales Of Dario Blood Glucose Monitoring System On Amazon PrimeBRIEF-Dariohealth Launches Sales Of Dario Blood Glucose Monitoring System On Amazon Prime
www.reuters.com - February 20 at 4:38 PM
DarioHealth Launches Sales of Dario™ Blood Glucose Monitoring System on Amazon PrimeDarioHealth Launches Sales of Dario™ Blood Glucose Monitoring System on Amazon Prime
finance.yahoo.com - February 20 at 9:16 AM
DarioHealth Partners With a Leading Diabetes ClinicDarioHealth Partners With a Leading Diabetes Clinic
finance.yahoo.com - February 12 at 4:42 PM
DarioHealth Wins Key Contract Ensuring Its Platform to be Utilized in Clinical StudyDarioHealth Wins Key Contract Ensuring Its Platform to be Utilized in Clinical Study
finance.yahoo.com - February 8 at 9:03 AM
dynaCERT Appoints Colonel Yalon Farhi as Director, Provides Corporate Update Including Equity Financing and Note RedemptiondynaCERT Appoints Colonel Yalon Farhi as Director, Provides Corporate Update Including Equity Financing and Note Redemption
finance.yahoo.com - January 31 at 9:11 AM
DarioHealth Introduces iPhone 7, iPhone 8, and iPhone X Compatible Smart Glucose Meter to the Australian MarketDarioHealth Introduces iPhone 7, iPhone 8, and iPhone X Compatible Smart Glucose Meter to the Australian Market
finance.yahoo.com - January 17 at 9:57 AM
DarioHealth Begins Selling iPhone 7, iPhone 8, and iPhone X Smart Glucose Meter in the U.K.DarioHealth Begins Selling iPhone 7, iPhone 8, and iPhone X Smart Glucose Meter in the U.K.
finance.yahoo.com - January 8 at 9:22 AM
What You Must Know About DarioHealth Corp’s (NASDAQ:DRIO) Major InvestorsWhat You Must Know About DarioHealth Corp’s (NASDAQ:DRIO) Major Investors
finance.yahoo.com - December 27 at 8:35 PM
DarioHealth Granted Another U.S. Patent Strengthening its Core TechnologyDarioHealth Granted Another U.S. Patent Strengthening its Core Technology
finance.yahoo.com - December 27 at 3:34 PM
Aegis Reaffirms "Buy" Rating for DarioHealth (DRIO)Aegis Reaffirms "Buy" Rating for DarioHealth (DRIO)
www.americanbankingnews.com - December 25 at 12:40 AM
DarioHealth Gains Regulatory Approval in Australia for iPhone 7, iPhone 8, and iPhone X Smart Glucose MeterDarioHealth Gains Regulatory Approval in Australia for iPhone 7, iPhone 8, and iPhone X Smart Glucose Meter
finance.yahoo.com - December 18 at 10:23 AM
Does Zero-Debt Make DarioHealth Corp (DRIO) A Financially Strong Company?Does Zero-Debt Make DarioHealth Corp (DRIO) A Financially Strong Company?
finance.yahoo.com - December 9 at 10:03 AM
Should You Be Content With DarioHealth Corp’s (DRIO) 55.7% Earnings Growth?Should You Be Content With DarioHealth Corp’s (DRIO) 55.7% Earnings Growth?
finance.yahoo.com - November 30 at 4:49 PM
DarioHealth Corp. :DRIO-US: Earnings Analysis: Q3, 2017 By the Numbers : November 29, 2017DarioHealth Corp. :DRIO-US: Earnings Analysis: Q3, 2017 By the Numbers : November 29, 2017
finance.yahoo.com - November 29 at 10:09 AM
DarioHealth Launches Version 3.5 of its MyDario App to Support iPhone 7 and iPhone 8DarioHealth Launches Version 3.5 of its MyDario App to Support iPhone 7 and iPhone 8
finance.yahoo.com - November 20 at 9:09 AM
DarioHealths (DRIO) CEO Erez Raphael on Q3 2017 Results - Earnings Call TranscriptDarioHealth's (DRIO) CEO Erez Raphael on Q3 2017 Results - Earnings Call Transcript
seekingalpha.com - November 14 at 6:27 PM
DarioHealth Corp. to Host Earnings CallDarioHealth Corp. to Host Earnings Call
finance.yahoo.com - November 14 at 6:27 PM
DarioHealth Reports Third Quarter 2017 ResultsDarioHealth Reports Third Quarter 2017 Results
finance.yahoo.com - November 14 at 6:27 PM
What Can We Expect for DarioHealth Corp (DRIO) Moving Forward?What Can We Expect for DarioHealth Corp (DRIO) Moving Forward?
finance.yahoo.com - November 14 at 6:27 PM
Investor Network Invites You to the DarioHealth Third Quarter 2017 Earnings Conference Call and Webcast Live on Tuesday, November 14, 2017Investor Network Invites You to the DarioHealth Third Quarter 2017 Earnings Conference Call and Webcast Live on Tuesday, November 14, 2017
finance.yahoo.com - November 13 at 6:38 PM
DarioHealth to Host Third Quarter Conference Call on November 14, 2017DarioHealth to Host Third Quarter Conference Call on November 14, 2017
finance.yahoo.com - November 6 at 7:27 PM
DarioHealth Corp. (DRIO) Set to Announce Earnings on WednesdayDarioHealth Corp. (DRIO) Set to Announce Earnings on Wednesday
www.americanbankingnews.com - November 1 at 4:28 AM

SEC Filings

DarioHealth (NASDAQ:DRIO) SEC Filings

This page is loading this company's SEC Filings. Please wait...

Social Media

Financials

Financials are not available for this stock.

Chart

DarioHealth (NASDAQ DRIO) Stock Chart for Saturday, May, 26, 2018

Loading chart…

This page was last updated on 5/26/2018 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.